ABUS vs HAL
Arbutus Biopharma Corp (ABUS) versus Halliburton Company (HAL) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
HAL does not have a complete income-statement cache yet.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Not investment advice. Open the ABUS and HAL stock pages for the full models.
Not investment advice.